August 10, 2020. Experts urge that COVID-19 vaccines are made widely available only after the Food and Drug Administration (FDA) has been able to evaluate safety and efficacy data from completed Phase 3 clinical trials.
Read More »On Health Policy
NCHR joins Nonprofits in criticizing White House blocking CDC from sharing Covid-19 data
July 23, 2020. Nonprofit coalition asks Sec. Azar to rescind guidance to stop reporting coronavirus data to CDC and send it only to HHS.
Read More »NCHR’s Comments on USPSTF’s Draft Recommendation Statement for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
We strongly agree with the USPSTF’s recommendation that all physicians ask their adult patients and pregnant patients about their tobacco use. However, encourage the USPSTF to consider two suggestions that would strengthen this recommendation.
Read More »NCHR’s Comments on USPSTF’s Draft Research Plan for Cardiovascular Disease Prevention
June 8, 2020. We support the US Preventive Services Task Force’s efforts to update recommendations based on new scientific evidence.
Read More »NCHR’s Comments on USPSTF’s Draft Recommendation Statement Regarding Screening for Hepatitis B Virus Infection
June 1, 2020. We agree with the “B” grade to recommend hepatitis B virus infection screening in nonpregnant adolescents and adults at an increased risk for infection.
Read More »


